2 weeks Pharma Stock Roundup: FDA Updates for JNJ, GSK, PFE, NVO’s Expanded Deal Zacks

FDA grants priority review tag to JNJ’s nipocalimab BLA for gMG and asks for new warnings on GSK & PFE’s RSV vaccine labels.

Johnson & Johnson (JNJ) · Pfizer (PFE)